One Of Biotech's Biggest Investors Says The Industry Must Be 'Unreasonable'
Noubar Afeyan is one of biotech's most prolific investors.
View ArticleAffording Miracles: As Biotech Victories In Gene Therapy Excite, Costs Spur...
The first-approved gene therapy costs an eye-popping $142,000 per drop, helping to spur the quest to find better ways of pricing and paying for these miraculous new treatments.
View ArticleUMass Inventor Insists On Due Credit For Nurses Who Innovate
A UMass Amherst nursing professor has been named to a national panel of inventors -- the first nurse to be honored alongside engineers and computer scientists.
View ArticleNumber Of Women Leaders At Biotech Companies Lags — But Is Improving
Two leaders in biotech -- both women -- discuss how women in management benefit biotech companies, and what's being done to bring more women into executive office suites and board rooms.
View ArticleNext Chapter For Biotech? Many Say 'Convergence' With Data Science
Artificial intelligence, big data analytics and deep learning are converging on health care in a big way, experts insist.
View ArticleCould The 'BioBoom' Go Bust? How One MIT Professor Sees It
The hope and promise of lifesaving medical treatments fuel biotech investor exuberance to the tune of billions of dollars per year in Massachusetts. MIT's Andrew Lo breaks down how a biotech bubble...
View ArticleNext Era For Biotech: Designer Cells To Attack Diseases
A biotech CEO argues that the biggest news in the sector is not the creation of cures for specific diseases but rather of whole new types of treatments.
View ArticleToll Of Twitter Trolls: Study Delves Into Social Media's Link To Depression
Negative social media interactions may increase depression in young adults, but positive encounters don't prevent it, a study finds.
View ArticleMass. Sues Purdue Pharma Over 670 Residents Who Fatally Overdosed On Opioids
The state is suing Purdue Pharma on behalf of residents who were prescribed OxyContin, became addicted to opioids, overdosed and died.
View ArticleAbrupt Resignation Of Harvard Pilgrim CEO Will Have 'No Impact' On Talks With...
The abrupt resignation of Harvard Pilgrim CEO and President Eric Schultz comes during ongoing discussions with Partners HealthCare that some believe could result in a merger.
View ArticleHouse OKs Clark Bill That Would Offer Student Loan Help For Some Substance...
The measure cosponsored by Rep. Katherine Clark would offer student loan repayment for participants who agree to work as a treatment professional in areas most in need of their services.
View ArticleHarvard Scientists Aim To Reverse Diabetes With 'Surgery In A Pill'
A team of researchers at Brigham and Women's Hospital is developing a pill that packs the anti-diabetes benefits of weight-loss surgery -- without the operation.
View ArticleThe Science Behind Babies With 3 Parents
A professor in reproductive technologies explains the science behind three-parent babies, and why headlines may misconstrue who counts as a parent.
View ArticleNow We See: How The Opioid Crisis Has Laid Bare Deep Flaws In American Medicine
The physician-fueled opioid crisis, Dr. Elisabeth Poorman writes, is "the result of an effective marketing campaign that has killed hundreds of thousands of people."
View ArticlePills With Embedded Computer Sensors To Treat Mental Illnesses Raise...
A sociologist questions the ethics of Abilify MyCite, an antipsychotic drug with a built-in digital sensor to monitor adherence.
View ArticleBaker Signs Bill Allotting Nearly Half A Billion to Mass. Life Sciences
Governor Baker signs a much-anticipated life sciences bill.
View ArticleNurse Staffing Initiative Petition Survives Court Challenge
The initiative petition seeks to impose limits on the number of patients a nurse can be assigned to care for at a time.
View ArticleOpiate Addiction And The History Of Pain And Race In The U.S.
A professor in social medicine describes the origins of opiates in America, and how centuries-old racial biases continue to shape our views on addiction.
View ArticleMan Awarded $18.4 Million By Boston Jury In Lawsuit Over Canceled HIV Test
A Boston federal jury has awarded $18.4 million in damages to a man who said in a lawsuit that two doctors failed to test him for HIV, which allowed the virus to progress to AIDS.
View ArticleGawande Will Lead Boston-Based Health Co. Formed By Amazon, Berkshire...
Dr. Atul Gawande has been picked as the head of a new company. Its goal is reduce health care costs for American employees working at the three firms.
View Article